Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Sep-23
- 20-Jun-24
- 18-Jul-24
- 15-Aug-24
- 12-Sep-24
Select bar for recommendation details.
Recommendations | 12-Sep-24 | |
---|---|---|
Buy | 6 | |
Outperform | 7 | |
Hold | 4 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 15 analysts offering 12 month price targets for Kymera Therapeutics Inc have a median target of 52.00, with a high estimate of 106.00 and a low estimate of 36.00. The median estimate represents a 6.06% increase from the last price of 49.03.
High | 116.2% | 106.00 |
Med | 6.1% | 52.00 |
Low | -26.6% | 36.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Oct 31, 2024.
Average growth rate | -30.54% |
Average growth rate | +2.84% |
More ▼
Revenue history & estimates in USD
Average growth rate | +228.06% |
Average growth rate | +48.71% |
More ▼